Brought to you by:
SVS creates limb salvage-focused Frank J. Veith Lectureship
Next year’s Vascular Annual Meeting (VAM) will include a new named lecture: the Frank J. Veith Lecture, named in honor of former Society for Vascular Surgery (SVS) President Frank Veith, MD. Immediate Past President Ali AbuRahma, MD, announced the new…
New project will develop nanoparticles with imaging and medicine-delivery capabilities to better treat PAD
A University of Texas at Arlington bioengineer is leading a project to develop biodegradable nanomaterials that will take pictures and deliver medicine to combat peripheral arterial disease (PAD), the university announced in a press release. Kytai Nguyen, a UTA bioengineering…
First results from BEST-CLI poised to reveal ‘very low’ quality of life for patients entering the trial, especially women
An analysis from the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial presented at the 2022 Vascular Annual Meeting (VAM) demonstrated patient-specific variables such as self-reported female gender, current smoking, impaired mobility and opioid…
Study demonstrates feasibility, effectiveness of at-home exercise therapy plus cognitive behavior therapy for IC
A mobile phone-administered, home-based exercise therapy program for patients with intermittent claudication (IC) incorporating cognitive behavior therapy (CBT) was found to be feasible, with 78% of participants completing the whole course, the 2022 Vascular Annual Meeting (VAM) heard. The findings…
Researchers report higher three-year amputation and reintervention rates in Black and Hispanic CLTI patients
In a study of over 7,000 chronic limb-threatening ischemia (CLTI) patients, researchers found that Black and Hispanic patients had higher three-year amputation and reintervention rates; survival, however, was higher among Black patients and similar between Hispanic and White patients. Aderike…
Open surgical bypass to distal targets at the ankle is ‘viable’ infrapopliteal CLTI treatment
The Vascular and Endovascular Surgical Society (VESS) Paper Session at the Vascular Annual Meeting (VAM) in Boston on Wednesday, June 15, will see Othman M. Abdul-Malak, MD, from the University of Pittsburgh Medical Center in Pittsburgh, deliver results from “Midterm…
Revascularization strategy for BTK intervention should hinge on diagnostic modality, LINC hears
New data provide “another argument” for the use of intravascular ultrasound (IVUS) in below-the-knee (BTK) interventions. This is according to Michael Lichtenberg, MD, from Arnsberg Vascular Center in Arnsberg, Germany, who presented one-year outcomes from the PRESTIGE pilot study at the…
Register today for two SVS courses
Registration has opened—along with early-bird pricing—for two Society for Vascular Surgery (SVS) in-person courses in coding and reimbursement, and peripheral artery disease (PAD) skills. Both will be held in October after being postponed in 2021 because of a surge in…
Medtronic gains FDA nod for IN.PACT 018 DCB
Medtronic has announced approval from the Food and Drug Administration (FDA) for the IN.PACT 018 paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter, a drug-coated balloon (DCB), indicated for the interventional treatment of peripheral arterial disease (PAD) in the superficial femoral…
New long-term data of paclitaxel devices continue to show no increased mortality compared to non-drug coated devices
New long-term data from the SAFE-PAD (Safety assessment of femoropopliteal endovascular treatment with paclitaxel-coated devices) study were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions (May 19–22) in Atlanta. The analysis…